Transcription Factor ChREBP Mediates High Glucose-Evoked Increase in HIF-1α Content in Epithelial Cells of Renal Proximal Tubules
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Hyperglycemia/diabetes appears to be accompanied by the state of hypoxia, which especially affects kidneys. The aim of the study was to elucidate the mechanism of high glucose action on HIF-1α expression in renal proximal tubule epithelial cells. The research hypotheses included: (1) the participation of transcription factor ChREBP; and (2) the involvement of the effects resulting from pseudohypoxia, i.e., lowered intracellular NAD+/NADH ratio. The experiments were performed on HK-2 cells and primary cells: D-RPTEC (Diseased Human Renal Proximal Tubule Epithelial Cells-Diabetes Type II) and RPTEC (Renal Proximal Tubule Epithelial Cells). Protein and mRNA contents were determined by Western blot and RT-qPCR, respectively. ChREBP binding to DNA was detected applying chromatin immunoprecipitation, followed by RT-qPCR. Gene knockdown was performed using siRNA. Sirtuin activity and NAD/NADH ratio were measured with commercially available kits. It was found that high glucose in HK-2 cells incubated under normoxic conditions: (1) activated transcription of HIF-1 target genes, elevated HIF-1α and ChREBP content, and increased the efficacy of ChREBP binding to promoter region of gene; and (2), although it lowered NAD/NADH ratio, it affected neither sirtuin activity nor HIF-1α acetylation level. The stimulatory effect of high glucose on HIF-1α expression was not observed upon the knockdown of ChREBP encoding gene. Experiments on RPTEC and D-RPTEC cells demonstrated that HIF-1α content in diabetic proximal tubular cells was lower than that in normal ones but remained high glucose-sensitive, and the latter phenomenon was mediated by ChREBP. Thus, it is concluded that the mechanism of high glucose-evoked increase in HIF-1α content in renal proximal tubule endothelial cells involves activation of ChREBP, indirectly capable of gene up-regulation.
Yao P, Wu L, Yao H, Shen W, Hu P Eur J Med Res. 2024; 29(1):546.
PMID: 39538358 PMC: 11562611. DOI: 10.1186/s40001-024-02129-3.
Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome.
Rong J, Zhang Z, Peng X, Li P, Zhao T, Zhong Y Int J Biol Sci. 2024; 20(12):4783-4798.
PMID: 39309427 PMC: 11414397. DOI: 10.7150/ijbs.100394.
Rui Y, Zhang X, Xie H, Qi H, Liu R, Zeng N Acta Diabetol. 2024; 61(11):1375-1384.
PMID: 38847922 DOI: 10.1007/s00592-024-02288-z.
Chen X, Tian F, Sun Z, Zeng G, Tang P J Diabetes Res. 2022; 2022:9611509.
PMID: 36465705 PMC: 9711992. DOI: 10.1155/2022/9611509.
Xie J, Zhong F, Guo Z, Li X, Wang J, Gao Z Front Endocrinol (Lausanne). 2022; 13:960835.
PMID: 36237185 PMC: 9551351. DOI: 10.3389/fendo.2022.960835.